?
¿TIENE DUDAS
SOBRE APOQUEL®?
Recuerde que hay diferentes causas que originan prurito y
se
requiere una metodología específica y cierto tiempo (hasta meses)
para
diagnosticarlas.
APOQUEL® SE DEBE DE ADMINSITRAR
TAN PRONTO COMO SEA POSIBLE
Y DURANTE EL TIEMPO QUE SEA NECESARIO
GUÍA DE DOSIFICACIÓN
rango de peso en kg | número de tabletas que se deben administrar | |||
BAJO | ALTO | APOQUEL® 3.6 mg |
APOQUEL® 5.4 mg |
APOQUEL® 16 mg |
3.0 | 4.4 | 1/2 |
--- | --- |
4.5 | 5.9 | --- | 1/2 |
--- |
6.0 | 8.9 | 1 |
--- | --- |
9.0 | 13.4 | --- | 1 |
--- |
13.5 | 19.9 | --- | --- | 1/2 |
20.0 | 26.9 | --- | 2 |
--- |
27.0 | 39.9 | --- | --- | 1 |
40.0 | 54.9 | --- | --- | 11/2 |
55.0 | 80.0 | --- | --- | 2 |
RECOMENDACIONES DE TRATAMIENTO DESPUÉS DE DOSIFICACIÓN
1. Gadeyne C, Little P, King VL, Edwards N, Davis K, Stegemann MR. Efficacy of oclacitinib (Apoquel®) compared with prednisolone for the control of pruritus and clinical signs associated with allergic dermatitis in client-owned dogs in Australia. Vet Dermatol. 2014;25(6):512-518, e86. doi: 10.1111/vde.12166.
2. Cosgrove SB, Wren JA, Cleaver DM, et al. Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis. Vet Dermatol. 2013;24(5): 479-e114. doi: 10.1111/vde.12047
3. Cosgrove SB, Cleaver DM, King VL, et al. Long-term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of life. Vet Dermatol. 2015;26(3):171-179, e35.
4. Sousa CA. Glucocorticoids in veterinary dermatology. In: Bonagura JD, Twedt DC, eds. Kirk’s Current Veterinary Therapy. 14th ed. St. Louis, MO: Saunders Elsevier; 2009:400-404.
5. Hill PB, et al. Vet Rec. 2006;158(16):533-539.
6. Valdman- Grinshpoun Y. et al, Dermatol Res Pract 2012 – 1- 6
7. Marsella R, et al. J Am Vet Med Assoc 2012;241(2):194-207
8. Gonzalez A, Bowman J, Fici G, Zhang M, Mann D, Mitton-Fry M. Oclacitinib (Apoquel) is a novel Janus kinase inhibitor with activity against oytokines involved in allergy. J. vet Pharmacol Ther. In press.
9. Cosgrove SB, et al. Vet Dermatol. 2013; 24:587-e142
Registros propiedad de Zoetis México, S. de R.L. de C.V. **Apoquel® 5.4 mg (Oclacitinib) Reg. SAGARPA Q-1196-717; **Apoquel® 16 mg (Oclacitinib) Reg. SAGARPA Q-1196-718; **Apoquel® 3.6 mg (Oclacitinib) Reg. SAGARPA Q-1196-719. USO VETERINARIO. Consulte Al Médico Veterinario. **Su Venta Requiere Receta Médica. Paseo de los Tamarindos No.60 PB, Col. Bosques de las Lomas, México, CDMX, C.P. 05120.